课题基金 / 基金详情

8TH INTERNATIONAL CONGRESS ON INFECTIOUS DISEASES

8TH INTERNATIONAL CONGRESS ON INFECTIOUS DISEASES
第八届国际传染病大会
批准号:
2555661
负责人:
Dennis L. Kasper
金额:
$0.5万
依托单位国家:
美国
项目类别:
财政年份:
1998
资助国家:
美国
项目状态:
已结题
起止时间:
1998-05-15 至 1999-05-14

项目摘要

项目成果

Dennis L. Kasper的其他基金

相似基金

相关文献

中文摘要
翻译
请求提供支持,以允许20名年轻美国调查人员在传染病 疾病将出席第八届国际传染病大会 (ICID)将于1998年5月15日至18日在波士顿举行。大会带来了 与来自100个国家的5000多名与会者一起讨论 微生物学和生物医学领域的科学和临床进展 传染病。除了允许年轻的美国调查人员与 并与国际知名的调查人员互动,第八届ICID 在国际传染病会议中独一无二地吸引了 来自发展中国家的医生和科学家的广泛参与 国家。2000年健康人的目标包括减少 结核病、人类免疫缺陷病毒、可预防的疫苗 疾病,以及防止新的传染性疾病的出现 疾病,实现这些目标越来越需要国际社会 努力与合作。例子包括应对不断上升的 在外国出生的美国结核病病例和国际艾滋病毒的百分比 疫苗试验。此外,资源贫乏的国家首当其冲 新发和再发传染病的发病率和死亡率 疾病。与当地同事一起在这些国家进行调查将 对美国调查人员来说至关重要,要参与到了解 以及对这些疾病的控制。贯穿始终的对艾滋病毒的早期研究 非洲,最近加蓬的埃博拉病毒研究中心 疾病控制和预防,以及正在进行的合作,包括 美国和南美调查人员了解分子 肺炎链球菌对抗生素耐药的流行病学 这些关系的重要性的例子。第八届ICID将 帮助年轻的美国调查人员建立联系和关系 对于这些国际努力来说是必要的。临床工作座谈会 治疗的最新进展,传统和分子流行病学的进展, 感染控制实践、免疫学和分子生物学的发展 遗传学和微生物学将包括在内。节目内容为 由一个国际已知传染病委员会监督 医生和科学家。委员会和国会都是 国际传染病学会的责任 (ISID)第八届ICID由传染病协会共同赞助 美国学会和钱宁实验室,一个分部 布里格姆妇女医院医学部和哈佛医学院 学校。该计划的部分内容预计将被认证为 继续医学教育学分。
英文摘要
Support is request to permit 20 young US investigators in infectious diseases to attend the 8th International Congress for Infectious Disease (ICID) to be held in Boston from May 15-18 1998. The Congress brings together over 5,000 participants from 100 countries to discuss the spectrum of scientific and clinical advances in microbiology and infectious diseases. Besides allowing young US investigators to meet and to interact with internationally known investigators, the 8th ICID is unique among international infectious disease meetings in attracting broad participation from physicians and scientists from developing countries. Goals of Healthy People 2000 include the reduction of tuberculosis, human immunodeficiency virus, vaccine preventable diseases, and the prevention of the emergence of new infectious diseases, Achieving these goals increasingly requires international efforts and cooperation. Examples include studies to address the rising percentage of foreign-born US tuberculosis cases and international HIV vaccine trials. Furthermore, resource poor countries bear the brunt of morbidity and mortality from emerging and re-emerging infectious diseases. Investigations in these countries with local colleagues will be essential for US investigators to be involved in the understanding and control of these diseases. The early studies of HIV throughout Africa, the recent work on Ebola virus in Gabon by the Centers for Disease control and Prevention, and the ongoing collaborations involving US and South American investigators to understand the molecular epidemiology of antibiotic resistant Streptococcus pneumoniae are examples of the importance of these relationships. The 8th ICID will help young US investigators develop the contacts and relationships necessary for these international efforts. Symposia on clinical treatment updates, advances in traditional and molecular epidemiology, infection control practices, developments in immunology and molecular genetics and microbiology will be included. The program content is overseen by a committee of internationally known infectious disease physicians and scientists. Both the Committee and the Congress are the responsibility of the International Society for Infectious Diseases (ISID) The 8th ICID is being co-sponsored by the Infectious Diseases Society of America and the Channing laboratory, a division of the Brigham and Women's Hospital Department of Medicine and Harvard Medical School. Portions of the program are expected to be accredited for continuing medical education credits.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Elucidating the Structural Requirements for Next-Gen Glycoconjugate Vaccines
  • 批准号:
    10321266
  • 项目类别:
  • 资助金额:
    $60.46万
  • 财政年份:
    2020
  • 负责人:
    Dennis L. Kasper
  • 依托单位:
Elucidating the Structural Requirements for Next-Gen Glycoconjugate Vaccines
  • 批准号:
    10533764
  • 项目类别:
  • 资助金额:
    $61.31万
  • 财政年份:
    2020
  • 负责人:
    Dennis L. Kasper
  • 依托单位:
Elucidating the Structural Requirements for Next-Gen Glycoconjugate Vaccines
  • 批准号:
    10084269
  • 项目类别:
  • 资助金额:
    $60.46万
  • 财政年份:
    2020
  • 负责人:
    Dennis L. Kasper
  • 依托单位:
Innovative Platforms for Antimicrobial Therapy and Vaccine Development
  • 批准号:
    8791872
  • 项目类别:
  • 资助金额:
    $493.25万
  • 财政年份:
    2014
  • 负责人:
    Dennis L. Kasper
  • 依托单位:
海外基金